← Back to Search

Gastrograﬁn for Small Bowel Obstruction

Phase 2 & 3

Waitlist Available

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 6 months

Awards & highlights

Study Summary

This trial is testing whether adding Gastrografin to standard non-surgical management of small bowel obstruction is effective.

Eligible Conditions

Small Bowel Obstruction

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

rate of surgical intervention

Secondary outcome measures

Length of hospital stay

Rate of complications

Time to first feed

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Gastrografin ArmExperimental Treatment1 Intervention

Patients will receive a single dose of undiluted Gastrografin via the nasogastric tube at 24 hours after admission for small bowel obstruction. The dose of Gastrografin will be proportional to the patient's weight and age and will be based off of the recommendations from the drug manufacturer. Dosages will range from 30 ml for infants to children less than 5 years old and 60 ml for children 5-18 years and will not be diluted.

Group II: Control ArmExperimental Treatment1 Intervention

Patients will receive a single dose of saline solution via the nasogastric tube at 24 hours after admission for small bowel obstruction. The volume of saline solution will be proportional to the volume of Gastrografin patients of similar weight and age would receive.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor

656 Previous Clinical Trials

413,426 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is Gastrografin given to patients?

"Gastrografin is an eﬀective agent for retrograde cystourethrography, arteriography, and computerized tomography."

Answered by AI

Are there any open positions in this trial for willing participants?

"That is accurate. According to the information available on clinicaltrials.gov, this trial was posted on September 1st, 2019 and is currently recruiting patients. The study plans to admit a total of 146 participants from one site."

Answered by AI

Does this research include patients who are octogenarians or above?

"Children aged 6 months to 18 years old may qualify for this particular trial, though there are other studies more suited for different age groups. For example, there are 3 trials specifically designed for those under 18 and 13 trials investigating treatments for seniors above the age of 65."

Answered by AI

What is the research history of Gastrograﬁn?

"Currently, there is 1 trial studying Gastrografin that is in Phase 3. Out of the total trials for Gastrografin, most are located in London, Ontario with one other location running a study."

Answered by AI

How many people are partaking in this clinical trial at most?

"That is accurate. The listing on clinicaltrials.gov says that the research team is still looking for participants. This study was first made public on September 1st, 2019 and had new information added as recently as April 5th, 2022. So far, 146 people have signed up to take part in this experiment at a single location."

Answered by AI

Could I possibly join this clinical trial?

"Eligible patients for this trial must have intestinal obstruction and be between 6 months old to 18 years old. The study is looking to enroll 146 participants in total."

Answered by AI

Recent research and studies

Acta PaediatricaJournal

Hypothyroidism in Neonates Post-iodinated Contrast Media: A Systematic Review

Ahmet, Alexandra, Margaret L Lawson, Paul Babyn, and Andrea C Tricco. 2009. “Hypothyroidism in Neonates Post-iodinated Contrast Media: A Systematic Review”. Acta Paediatrica. Wiley. doi:10.1111/j.1651-2227.2009.01412.x.

Journal of Pediatric SurgeryJournal

Enrollment and Reporting Practices in Pediatric General Surgical Randomized Clinical Trials: A Systematic Review and Observational Analysis

St-Louis, Etienne, Marcus Oosenbrug, Tara Landry, and Robert Baird. 2018. “Enrollment and Reporting Practices in Pediatric General Surgical Randomized Clinical Trials: A Systematic Review and Observational Analysis”. Journal of Pediatric Surgery. Elsevier BV. doi:10.1016/j.jpedsurg.2018.02.009.

Journal of Pediatric SurgeryJournal

The Role of Prospective Randomized Clinical Trials in Pediatric Surgery: State of the Art?

Moss, R.Lawrence, Marion C.W. Henry, Reed A. Dimmitt, Shawn Rangel, Nora Geraghty, and Erik D. Skarsgard. 2001. “The Role of Prospective Randomized Clinical Trials in Pediatric Surgery: State of the Art?”. Journal of Pediatric Surgery. Elsevier BV. doi:10.1053/jpsu.2001.25749.

Journal of Pediatric SurgeryJournal